BALDUZZI, ADRIANA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 19.280
AS - Asia 12.262
EU - Europa 9.083
SA - Sud America 1.908
Continente sconosciuto - Info sul continente non disponibili 1.027
AF - Africa 307
OC - Oceania 49
Totale 43.916
Nazione #
US - Stati Uniti d'America 18.261
SG - Singapore 3.949
IT - Italia 3.041
VN - Vietnam 2.408
CN - Cina 2.077
HK - Hong Kong 1.541
RU - Federazione Russa 1.533
BR - Brasile 1.399
DE - Germania 858
SE - Svezia 770
IE - Irlanda 756
CA - Canada 737
BD - Bangladesh 614
GB - Regno Unito 390
FR - Francia 388
IN - India 380
UA - Ucraina 315
FI - Finlandia 233
ID - Indonesia 193
AR - Argentina 176
KR - Corea 161
TR - Turchia 153
ES - Italia 140
JP - Giappone 132
MX - Messico 131
NL - Olanda 120
IQ - Iraq 111
PL - Polonia 100
ZA - Sudafrica 94
AT - Austria 85
EC - Ecuador 85
PH - Filippine 74
PK - Pakistan 73
CO - Colombia 62
VE - Venezuela 50
BE - Belgio 49
SA - Arabia Saudita 49
CH - Svizzera 46
CL - Cile 45
AU - Australia 40
UZ - Uzbekistan 39
LT - Lituania 38
CZ - Repubblica Ceca 37
GR - Grecia 37
IR - Iran 35
PY - Paraguay 33
MA - Marocco 32
EG - Egitto 31
IL - Israele 31
AE - Emirati Arabi Uniti 28
DK - Danimarca 28
JO - Giordania 28
KE - Kenya 28
JM - Giamaica 26
MY - Malesia 26
ET - Etiopia 25
TN - Tunisia 25
NP - Nepal 24
UY - Uruguay 23
PE - Perù 21
PT - Portogallo 21
TW - Taiwan 21
CR - Costa Rica 20
TH - Thailandia 17
HN - Honduras 15
KZ - Kazakistan 15
DO - Repubblica Dominicana 14
GT - Guatemala 14
PA - Panama 14
RO - Romania 14
BG - Bulgaria 13
DZ - Algeria 13
OM - Oman 13
TT - Trinidad e Tobago 13
AZ - Azerbaigian 12
AL - Albania 11
BO - Bolivia 11
NG - Nigeria 11
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
NZ - Nuova Zelanda 9
NI - Nicaragua 8
AO - Angola 7
BH - Bahrain 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
PS - Palestinian Territory 7
SV - El Salvador 7
NO - Norvegia 6
LV - Lettonia 5
LY - Libia 5
MU - Mauritius 5
PR - Porto Rico 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
EU - Europa 4
HR - Croazia 4
HU - Ungheria 4
Totale 42.815
Città #
Ann Arbor 2.176
Singapore 2.095
Ashburn 1.800
Hong Kong 1.506
San Jose 1.297
Fairfield 1.012
Milan 925
Woodbridge 811
Dublin 735
Ho Chi Minh City 735
Hanoi 606
Wilmington 601
Chandler 525
Houston 510
Toronto 489
New York 478
Santa Clara 472
Frankfurt am Main 466
Seattle 464
Dallas 424
Council Bluffs 411
Los Angeles 397
Chicago 365
Hefei 324
Cambridge 289
Dearborn 286
Beijing 278
Jacksonville 269
Rome 239
Princeton 235
The Dalles 198
Lauterbourg 168
Moscow 164
Seoul 148
São Paulo 146
Buffalo 143
Jakarta 131
Boardman 129
Phoenix 119
Shanghai 118
Helsinki 114
Lawrence 113
Nanjing 96
Altamura 92
Columbus 86
Munich 83
Da Nang 80
Orem 77
Atlanta 76
San Diego 75
Tokyo 73
Haiphong 71
Montreal 70
Denver 69
London 68
Rio de Janeiro 66
Nuremberg 64
Warsaw 64
Figino 61
Naples 61
Turin 56
Brooklyn 55
Baghdad 51
Biên Hòa 50
Salt Lake City 48
Andover 47
Ha Long 47
Chennai 46
Johannesburg 46
Guangzhou 45
Dhaka 42
Florence 41
Lappeenranta 41
Lissone 41
Kent 39
Quận Bình Thạnh 39
Turku 39
Fremont 38
Mexico City 38
Dong Ket 37
Tashkent 37
Lachine 36
New Delhi 36
Poplar 36
San Francisco 36
Miami 35
Washington 35
Brussels 34
Hải Dương 34
Vienna 34
Changsha 33
Genoa 33
Istanbul 33
Nanchang 33
Boston 32
Paris 32
Ankara 31
Stockholm 31
Tianjin 31
Amsterdam 30
Totale 25.801
Nome #
ABO incompatibile graft management in pediatric transplantation 743
Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations 588
Long-term complications after allogeneic hematopoietic stem cell transplantation for pediatric patients with acute leukemia or myelodysplastic syndrome given either a Treosulfan- or a Busulfan-based conditioning regimen: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study 504
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 503
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 485
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 479
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 478
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 477
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 457
Avascular necrosis of the talus in pediatric acute lymphoblastic leukemia: Current concepts 435
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 421
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 416
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 398
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 396
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: Practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group 395
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 381
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 367
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 358
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 354
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 348
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 346
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload 333
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 328
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 322
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 322
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 319
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 317
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015 314
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 312
Thyroid disorders following hematopoietic stem cell transplantation in childhood: the impact of the conditioning regimen on thyroid dysfunction, volume changes and occurrence of nodules 312
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 311
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 309
Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up 309
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 305
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche 300
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 299
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 294
Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life 293
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience 287
Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies 280
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 280
Pubertal attainment and Leydig cell function following pediatric hematopoietic stem cell transplantation: a three-decade longitudinal assessment 279
Late Adverse Events Following Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukaemia: State of the Art 277
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study 277
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 275
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 275
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 271
PENTRAXIN 3 PLASMA LEVELS AT GRAFT-VERSUS-HOST DISEASE ONSET PREDICT DISEASE SEVERITY AND RESPONSE TO THERAPY IN CHILDREN GIVEN HEMATOPOIETIC STEM CELL TRANSPLANTATION 262
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 262
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 262
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia 262
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis 259
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 258
Pentraxin-3 Increases At The Onset Of Graft-Versus-Host Disease In Transplanted Patients 255
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study 253
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 248
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 247
Donor selection in Adults and Pediatrics 244
Moebius syndrome and hypopituitarism: a case of multiple pituitary hormone deficiency and revision of the literature 243
Isolated leukopenia in children and adolescents referred to a Pediatric Hematology Clinic 242
Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: A study from the infectious diseases working party of the european group for blood and marrow transplantation 242
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission 241
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial 239
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia 235
Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study 235
Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach 232
Transplant-related toxicity and mortality: An AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia 231
The impact of MRD in HCT for childhood ALL 231
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing 231
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: The impact of the waiting time 230
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 229
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 228
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment 227
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome 225
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study 222
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (vhr) childhood acute lymphoblastic leukaemia in first complete remission 216
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG 214
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 214
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission 213
Successful sequential liver and hematopoietic stem cell transplantation in a patient with Fanconi anemia 211
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 210
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 210
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP) 210
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment 208
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 207
Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? 205
Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation 205
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions 205
Sport therapy: Allenamento di precisione dalla diagnosi al termine del trattamento oncologico in bambini e adolescenti con emopatia maligna [Sport therapy: Precision exercise training from diagnosis to the end of treatment in children/adolescents with malignant hemopathies] 205
A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization 202
Letermovir Primary and Secondary Prophylaxis in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplant 202
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival - an EBMT PDWP retrospective study 201
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial 201
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) 201
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes 200
Tetralogy of Fallot with absent pulmonary valve: definitive diagnosis by two-dimensional echocardiography 198
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children 198
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL 198
Osteopathic treatment and evaluation in the clinical setting of childhood hematological malignancies 198
Diagnostic Management of Pediatric Bronchiectasis: A Literature Review and Clinical Examples 198
Totale 29.034
Categoria #
all - tutte 140.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.361 0 0 229 159 78 113 74 86 129 122 130 241
2022/20232.682 318 716 163 186 225 418 53 195 217 25 92 74
2023/20242.385 77 69 133 123 300 544 458 88 238 54 77 224
2024/20256.752 345 882 361 307 455 259 311 244 674 862 752 1.300
2025/202619.042 2.332 1.384 1.289 2.015 1.790 833 2.270 774 1.805 1.719 1.157 1.674
2026/20273.512 1.031 1.318 1.163 0 0 0 0 0 0 0 0 0
Totale 43.916